In Coding
Mar 3rd, 2014
The Centers for Medicare & Medicaid Services (CMS) has removed the coverage of evidence (CED) requirement in the national coverage determination (NCD) for fluorodeoxyglucose (FDG) positron emission tomography (PET) for solid tumors, effective June 11, 2013. CMS will cover three FDG PET scans (without the CED requirement) when used to guide subsequent management of anti-tumor ...
Jun 1st, 2012
The Centers for Medicare & Medicaid Services (CMS) recently revised the National Coverage Determination (NCD) for Extracorporeal Photopheresis (110.4) to add coverage for the treatment of bronchiolitis obliterans syndrome (BOS) following lung allograft transplantation. Medicare coverage is effective for services rendered on or after April 30, 2012 when provided under a clinical research study a...
In Billing
Oct 15th, 2010
Effective for claims with service dates on or after Aug. 4, Medicare will nationally cover the use of allogenic hematopoietic stem cell transplantation (HSCT) for myelodysplastic syndrome (MDS) when provided in a Medicare-approved clinical study under Coverage Evidence Development (CED). In all other settings, HSCT for MDS is nationally non-covered by Medicare. MDS refers to ...
In CMS
Apr 5th, 2010
If your office filed claims for automatic implantable cardiac defibrillator (ICD) services provided in a clinical study on or after Oct. 1, 2007, which Medicare subsequently denied because the diagnosis code lacked the appropriate modifier, you may now be entitled to reimbursement. Denied ICD Claims Worth Another Look was last modified: July 5th, 2011 by admin aapc...